As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
Mumbai (Maharashtra) [India], July 27: Wockhardt Ltd – global pharmaceutical and biotechnology is aiming to turnaround its business operations and has perused important strategic initiatives for the same. Company is eying big on the restructuring of the US Business, vaccine tie-up with Serum
"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive® offers hope for a future free from annual outbreaks and epidemics in the African meningitis belt. It is a big moment as we, together, pave the way towards a healthier Africa
Keonjhar (Odisha) [India], May 19 (ANI/NewsVoir): Several titans of business, academics, sports, medicine and arts have come together in an unknown village Berunapadi, of Odisha, to commemorate the opening of the Utkal Gaurav International School (UGIS). The grand opening held in early March
Two companies are conducting trials to develop dengue vaccine, Director General, Indian Council of Medical Research Dr Rajeev Bahl told ANI on Tuesday.
Pune (Maharashtra) [India], April 25 (ANI/BusinessWire India): CRISIL Ratings Ltd (CRISIL) has upgraded the rating for long-term debt instruments and bank facilities of Poonawalla Fincorp Limited (PFL) to "CRISIL AAA (triple A)/ Stable".
Serum Institute of India Director Prakash Kumar Singh on Thursday presented Made in India HPV Vaccine Cervavac to Union Minister Jitendra Singh at the Union Minister's residence.
China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year.